Suppr超能文献

尾状叶切除术对肝门部胆管癌患者切缘状态和预后的影响:来自美国肝外胆管恶性肿瘤联盟的多机构分析。

The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium.

机构信息

Department of Surgery, University of Louisville, Louisville, KY.

Department of Surgery, Emory University, Atlanta, GA.

出版信息

Surgery. 2018 Apr;163(4):726-731. doi: 10.1016/j.surg.2017.10.028. Epub 2018 Jan 3.

Abstract

BACKGROUND

The objective of this study was to determine the impact of caudate resection on margin status and outcomes during resection of extrahepatic hilar cholangiocarcinoma.

METHODS

A database of 1,092 patients treated for biliary malignancies at institutions of the Extrahepatic Biliary Malignancy Consortium was queried for individuals undergoing curative-intent resection for extrahepatic hilar cholangiocarcinoma. Patients who did versus did not undergo concomitant caudate resection were compared with regard to demographic, baseline, and tumor characteristics as well as perioperative outcomes.

RESULTS

A total of 241 patients underwent resection for a hilar cholangiocarcinoma, of whom 85 underwent caudate resection. Patients undergoing caudate resection were less likely to have a final positive margin (P = .01). Kaplan-Meier curve of overall survival for patients undergoing caudate resection indicated no improvement over patients not undergoing caudate resection (P = .16). On multivariable analysis, caudate resection was not associated with improved overall survival or recurrence-free survival, although lymph node positivity was associated with worse overall survival and recurrence-free survival, and adjuvant chemoradiotherapy was associated with improved overall survival and recurrence-free survival.

CONCLUSION

Caudate resection is associated with a greater likelihood of margin-negative resection in patients with extrahepatic hilar cholangiocarcinoma. Precise preoperative imaging is critical to assess the extent of biliary involvement, so that all degrees of hepatic resections are possible at the time of the initial operation.

摘要

背景

本研究旨在确定尾状叶切除术对肝外胆管细胞癌切除时切缘状态和结果的影响。

方法

在外胆系恶性肿瘤协作组的机构中检索了治疗胆道恶性肿瘤的 1092 例患者数据库,以确定接受肝外胆管细胞癌根治性切除术的患者。比较了同时行尾状叶切除术与不行尾状叶切除术的患者的人口统计学、基线和肿瘤特征以及围手术期结局。

结果

共有 241 例患者因肝门部胆管癌接受了手术,其中 85 例行尾状叶切除术。行尾状叶切除术的患者最终阳性切缘的可能性较低(P=0.01)。行尾状叶切除术患者的总生存 Kaplan-Meier 曲线并未显示出优于未行尾状叶切除术患者的生存获益(P=0.16)。多变量分析显示,尾状叶切除术与总体生存率或无复发生存率的改善无关,尽管淋巴结阳性与总体生存率和无复发生存率的降低有关,而辅助放化疗与总体生存率和无复发生存率的改善有关。

结论

在肝外胆管细胞癌患者中,尾状叶切除术与阴性切缘的可能性更大相关。术前精确的影像学检查对于评估胆道受累的程度至关重要,以便在初次手术时能够进行所有程度的肝切除术。

相似文献

2
Resectable intrahepatic and hilar cholangiocarcinoma: Is margin status associated with survival?
Surgery. 2022 Mar;171(3):703-710. doi: 10.1016/j.surg.2021.09.038. Epub 2021 Dec 4.
7
Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
World J Gastroenterol. 2016 Feb 28;22(8):2601-10. doi: 10.3748/wjg.v22.i8.2601.
8
Effect of Margin Status on Survival After Resection of Hilar Cholangiocarcinoma in the Modern Era of Adjuvant Therapies.
Am Surg. 2021 Sep;87(9):1496-1503. doi: 10.1177/0003134820973401. Epub 2020 Dec 21.
9
Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
HPB (Oxford). 2012 Feb;14(2):142-9. doi: 10.1111/j.1477-2574.2011.00419.x. Epub 2011 Dec 12.

引用本文的文献

4
Practice guidelines for managing extrahepatic biliary tract cancers.
Ann Hepatobiliary Pancreat Surg. 2024 May 31;28(2):161-202. doi: 10.14701/ahbps.23-170. Epub 2024 Apr 29.
5
The State of Systematic Therapies in Clinic for Hepatobiliary Cancers.
J Hepatocell Carcinoma. 2024 Mar 27;11:629-649. doi: 10.2147/JHC.S454666. eCollection 2024.
8
Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers.
Ann Surg Oncol. 2023 Dec;30(13):7935-7949. doi: 10.1245/s10434-023-14255-z. Epub 2023 Sep 11.
10
Approach to Resectable Biliary Cancers.
Curr Treat Options Oncol. 2021 Sep 15;22(11):97. doi: 10.1007/s11864-021-00896-3.

本文引用的文献

1
Cancer statistics, 2016.
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
2
Hilar cholangiocarcinoma: expert consensus statement.
HPB (Oxford). 2015 Aug;17(8):691-9. doi: 10.1111/hpb.12450.
3
Perioperative Management of Hilar Cholangiocarcinoma.
J Gastrointest Surg. 2015 Oct;19(10):1889-99. doi: 10.1007/s11605-015-2854-8. Epub 2015 May 29.
4
Caudate lobe resections: a single-center experience and evaluation of factors predictive of outcomes.
World J Surg Oncol. 2013 Sep 5;11:220. doi: 10.1186/1477-7819-11-220.
5
Principles of surgical resection in hilar cholangiocarcinoma.
World J Gastrointest Oncol. 2013 Jul 15;5(7):139-46. doi: 10.4251/wjgo.v5.i7.139.
6
Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV.
Eur J Surg Oncol. 2012 Dec;38(12):1197-203. doi: 10.1016/j.ejso.2012.08.009. Epub 2012 Sep 16.
9
Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome.
Surg Today. 2004;34(11):885-90. doi: 10.1007/s00595-004-2832-3.
10
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.
J Hepatobiliary Pancreat Surg. 2000;7(2):155-62. doi: 10.1007/s005340050170.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验